STAT+: Amgen’s Repatha linked to fewer heart attacks
· statnews.com · popularity 33/100 · 0 similar stories today · Chronic Conditions (Health & Life Sciences)
Read the original at statnews.com →
Summary
Pithy intro text about the biopharma milieu. Novartis cites more tumor reports after Zolgensma Novartis has disclosed seven previously unreported cases of tumors in children who received Zolgensma, its gene therapy…
Found in: STAT News. Rating basis: single outlet; outlet tier 4; 1 feeds; feed position 5.